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Objective: To asses the relationship between maternal 
serum uric acid level and severity of hypertensive disorders 
in pregnancy and perinatal outcomes.
Methods: A cross sectional study was conducted at 
Persahabatan Hospital from January 2014 to December 
2018. Subject were  pregnant women with hypertensive 
disorder. Serum uric acid levels were taken from a venous 
blood sample at the time the patient came for delivery. 
The severity of hypertensive disorders in pregnancy were 
grouped into chronic hypertension, gestational hypertension, 
preeclampsia without severe feature, preeclampsia with 
severe feature, and preeclampsia with severe feature and 
organ involvement. The perinatal outcomes were the 
gestational age at birth, birth weight, and the fi rst minute 
APGAR score. The relationship between maternal serum 
uric acid level and severity of hypertensive disorders in 
pregnancy and perinatal outcomes were analyzed using 
Mann Whitney and Kruskall Wallis test.
Result: A total of 704 out of 880 pregnant women 
with hypertensive disorder have met the criteria as 
research subjects. Maternal uric acid levels were found to 
increase signifi cantly (p <0.001) with increasing severity 
of hypertensive disorders in pregnancy. Maternal who 
experienced preterm delivery had signifi cantly higher blood 
uric acid levels (p <0.001) than those who experienced a 
term delivery. Maternal blood uric acid levels of infants with 
small birth weight for gestational age and fi rst minute Apgar 
score <7 were slightly higher but not signifi cant compared 
to maternal blood uric acid levels of normal birth weight 
infants and fi rst minute Apgar score >7.
Conclusions: Maternal blood uric acid levels increased 
signifi cantly accompanying the severity of hypertensive 
disorders in pregnancy. Blood uric acid levels tend to be 
higher in maternal who have poor perinatal outcomes.
Keywords: APGAR score, hypertensive disorders in 
pregnancy, preeclampsia, uric acid.
Abstrak
Tujuan: Untuk menilai hubungan antara kadar asam 
urat serum ibu dan keparahan gangguan hipertensi pada 
kehamilan dan luaran perinatal.
Metode: Studi potong lintang dilakukan Rumah Sakit 
Persahabatan periode Januari 2014 sampai Desember 
2018. Subjek penelitian adalah ibu hamil dengan gangguan 
hipertensi. Kadar asam urat darah diambil dari sampel 
darah vena pada saat ibu hamil datang untuk melahirkan. 
Tingkat keparahan gangguan hipertensi pada kehamilan 
dikelompokkan menjadi hipertensi kronik, hipertensi 
gestasional, preeklamsia tanpa gejala berat, preeklamsia 
dengan gejaka berat, dan preeklamsia dengan gejala 
berat dan keterlibatan organ. Luaran perinatal adalah 
usia kehamilan saat lahir, berat badan bayi lahir, dan skor 
APGAR menit pertama. Hubungan antara kadar asam urat 
darah ibu dan tingkat keparahan gangguan hipertensi pada 
kehamilan dan luaran perinatal dianalisis menggunakan uji 
Mann Whitney atau uji Kruskall Wallis.
Hasil: Sebanyak 704 dari 880 ibu hamil penderita hipertensi 
telah memenuhi kriteria sebagai subjek penelitian. Kadar 
asam urat darah ibu meningkat secara signifi kan (p <0,001) 
dengan meningkatnya keparahan gangguan hipertensi 
pada kehamilan. Ibu yang melahirkan preterm memiliki 
kadar asam urat darah yang lebih tinggi secara bermakna 
(p < 0,001) dibandingkan ibu yang melahirkan aterm. Kadar 
asam urat darah ibu dari bayi dengan berat lahir kecil untuk 
usia kehamilan dan skor Apgar menit pertama < 7, sedikit 
lebih tinggi tetapi tidak signifi kan, dibandingkan kadar asam 
urat darah ibu dari bayi berat lahir normal dan skor Apgar 
menit pertama pertama > 7.
Kesimpulan: Kadar asam urat darah ibu meningkat secara 
signifi kan menyertai beratnya gangguan hipertensi pada 
kehamilan. Kadar asam urat darah cenderung lebih tinggi 
pada ibu yang memiliki luaran perinatal kurang baik.
Kata kunci: APGAR, asam urat, hipertensi dalam kehamilan, 
preeklamsia.
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Maternal mortality rate (MMR) is one of major 
health problems in Indonesia. In 2015, maternal 
mortality rate in Indonesia ranks among the 
highest among Southeast Asian countries at 305 
per 100,000 live births.1,2 This fi gure is still far from 
the Sustainable Development Goals target (SDG), 
which in 2030 expected that MMR in all countries 
will drop to under 70 per 100,000 live births.3,4 The 
three main causes of maternal death are bleeding 
(30%), hypertension (25%), and infections (12%).5 
Among those three main causes, hypertension is 
one of the most diffi cult problems to undertake 
in pregnancy, causing maternal and neonatal 
morbidity. In fact, there are more than 60,000 
maternal deaths worldwide each year due to 
hypertensive disorder in pregnancy.6
Based on guidelines from The American 
Congress of Obstetricians and Gynecologists 
(ACOG) in 2019, hypertensive disorders in 
pregnancy can be classifi ed into; Hypertension in 
pregnancy; chronic hypertension, preeclampsia 
without severe disorders (preeclampsia without 
severe features), and preeclampsia with severe 
disorders (severe preeclampsia feature).7 
Preeclampsia appears at 20 weeks after gestation, 
characterized by hypertension accompanied 
by proteinuria.8,9 There are many risk factors 
of hypertension in pregnancy, one of which is 
maternal serum uric acid level.9
Uric acid is a purine degradation product 
that is catalyzed by the enzyme xanthine 
dehydrogenase / xanthinoxidase (XDH / XO).10 
Previous studies reported a signifi cant increase 
in uric acid levels in 16% of patients with 
hypertension in pregnancy and 75% of patients 
with preeclampsia.11,12 Previous theory mentioned 
that elevated uric acid levels in the condition 
of preeclampsia is a secondary change caused 
by worsening of kidney function.13 However, 
other studies have shown that worsening in 
preeclampsia is characterized by an increase 
in maternal uric acid blood levels.14,15 Blood 
uric acid plays a role in the pathophysiology of 
preeclampsia through the process of inhibition 
of endothelial cell proliferation, trophoblast 
invasion, and inhibiting the release of nitric oxide 
(NO).16 This results in blood vessels with large 
diameters that do not respond to smooth muscle 
thereby making inadequate oxygen and nutrient 
transport. Other studies have even shown that 
increased uric acid in patients with preeclampsia 
can be seen since the 10th week of gestation, 
much earlier than the initial clinical symptoms 
shown by patients.14 However, there has not been 
any study analyzing the outcome of mothers with 
hypertensive disorders having elevated uric acid 
level in Indonesia.
This study aims to asses the relationship 
between maternal serum uric acid level and 
severity of hypertensive disorders in pregnancy 
and perinatal outcomes.
METHODS
This is a cross sectional study determined to 
assess the relationship between maternal serum 
uric acid level and various maternal and perinatal 
complications. This study was performed in 
January 2011 to December 2018, at Persahabatan 
General Hospital, Jakarta, Indonesia. Subjects 
were all pregnant mothers with hypertensive 
disorders having delivery during the course of 
the study. Mothers with history of serum uric acid 
level elevation before pregnancy due to chronic 
diseases such as arthritis gout or renal disease 
were excluded from the study. The samples were 
recruited using total sampling method.
This study use 5% error bound and 95% 
confi dence interval limit, power of the test 
considered to be 90%. The study was approved 
by the Research Ethics Committee, Faculty of 
Medicine, Universitas Indonesia with protocol 
number 17-03-0208 and Persahabatan General 
Hospital with ethical clearance number 09/KEPK-
RSUPP/02/2018. All patients who were included 
in this study had given their informed consent 
prior to their inclusion in the study.
Collected data were then analyzed using 
SPSS for Macintosh ver. 20. Characteristics of 
patients in the form of sociodemographic and 
clinicopathologically are analyzed descriptively. 
Serum uric acid levels were taken from a 
venous blood sample at the time the patient 
came for delivery. The maternal outcome in 
this study was the degree of hypertension and 
grade of hypertension. Severity of hypertensive 
disorder was grouped into chronic hypertension, 
gestational hypertension, preeclampsia without 
severe feature, preeclampsia with severe feature, 
and preeclampsia with severe feature and organ 
involvement. Chronic hypertension was defi ned as 
hypertensive disorder history prior to pregnancy. 
Gestational hypertension was defi ned as blood 
pressure of more than 140/90 mmHg after 20 
weeks of pregnancy without proteinuria or severe 
feature of preeclampsia. Preeclampsia without 
Vol 9. No 3. July 2021 A Signifi cant Increase in Maternal 145
146 Lisnawati, Berguna, Irwinda et al
Indones J
Obstet Gynecol
severe feature was defi ned as blood pressure 
between 140/90 mmHg and 160/110 mmHg with 
proteinuria. Preeclampsia with severe feature was 
defi ned as blood pressure of more than 160/110 
mmHg with proteinuria while preeclampsia with 
severe feature and organ involvement was defi ned 
as preeclampsia with or without proteinuria 
with either thrombocytopenia, liver dysfunction, 
renal insuffi ciency, pulmonary edema, new onset 
headache  unresponsive to medication, or new 
onset visual disturbance. The infant outcomes in 
this study were gestational age at birth, infant 
In order to determine the relationship between 
hypertensive disorder and serum uric acid 
level, hypertensive disorder categories suffered 
by patient was transformed into 3 different 
categories, namely 1) chronic hypertension 
In order to determine the relationship 
between maternal serum uric acid level and 
perinatal outcome, Kruskal Willis analysis was 
done between preterm birth, birth weight, and 
APGAR score with maternal serum uric acid level. 
(Table 3)
and gestational hypertension, 2) preeclampsia 
without severe feature, and 3) preeclampsia with 
severe feature with/without organ involvement. 
The result can be found on Table 2
birth weight according to the Lubchenco Curve 
and fi rst minute APGAR score. The relationship 
between uric acid levels and various outcomes 
was questioned using the Kruskal Willis and 
Mann Whitney test.
RESULTS
A total of 704 subjects met the inclusion 
criteria and had been further analyzed. Clinical 
variables were analyzed for its distribution and 
presented accordingly. (Table 1)
Table 1. Clinical Characteristics of Subjects
Table 2. Relationship between Hypertensive Disorder and Serum Uric Acid Level
Table 2. Relationship between Hypertensive Disorder and Serum Uric Acid Level
Chronic hypertension and gestational hypertension*
Preeclampsia without severe feature #





4.8 (2.2 – 8.0)
5.18 + 1.54
5.7 (2.2 – 16.0)
< 0.001+
#mean ± std deviation; *median (min – max)
#Mean ± std deviation; *median (min – max), +Kruskall Wallis test
*median (min – max), #Mann Whitney U test
Chronic hypertension#
Gestational hypertension*
Preeclampsia without severe feature#
Preeclampsia with severe feature*








4.9 (3.2 – 8.0)
5.18 + 1.54
5.3 (2.2 – 9.8)




















5.0 (2.2 – 9.8)
6.3 (2.7 – 16)
5.4 (2.2 – 14.5)
5.6 (2.7 – 16.0)
5.35 (2.2 – 14.5)












n (%) Serum uric acid 
(mg/dL)
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Based on the analysis done, it was known that 
preterm birth babies tend to be born by mother 
with higher level of serum uric acid (p < 0.001). 
There was no relationship between maternal 
serum uric acid with birth weight and fi rst minute 
APGAR Score (p > 0.05).
DISCUSSION
According to ACOG 2013 and 2019, 
hypertension disorders in pregnancy are divided 
into 4 groups, namely chronic hypertension, 
hypertension in pregnancy, preeclampsia without 
severe symptoms, and preeclampsia with severe 
symptoms.7 In this study, it was found that 
there was signifi cant difference between groups 
(p<0.001). Studies have reported that increased 
maternal and perinatal complications were 
associated with higher maternal blood uric acid 
levels >6 mg / dL in preeclampsia patients.10,11
There are several studies assessing the 
pathophysiology behind increased severity 
of hypertensive disorders in pregnancy due 
to higher maternal uric acid level, namely 
endothelial dysfunction due to high oxidative 
stress, decreased NO levels suppressing the 
ability of vasodilation of blood vessels and 
increase vascular tone, especially placental 
vascularization, as well as increased vasopressor 
levels such as endothelin and thromboxane. 
One study has shown that administration 
of allopurinol in women with hypertensive 
disorders in pregnancy can reduce the incidence 
of endothelial dysfunction and improve vascular 
vasodilation.13 Previous studies reported that 
condition of hypertension accompanied by 
hyperuricemia had the same risk of having 
preeclampsia compared to pregnant women with 
hypertension accompanied by proteinuria. In this 
study, it was not explained about the degree of 
hypertension in patients.17
Based on the analysis conducted in this 
study, maternal having preterm birth had higher 
level of serum uric acid (p <0.001). Previous 
studies suggested that hyperuricemia condition 
increases incidence of preterm birth, especially in 
patients with preeclampsia. However, the study 
also showed that patients with hyperuricemia 
without preeclampsia were more likely to have 
preterm births than patients with normal uric 
acid levels.13 Previous study also reported that 
increased maternal blood uric acid levels are 
associated with stunted fetal development and 
low birth weight babies.18 Other studies in India 
show that 100% of patients with blood uric acid 
levels > 5.5 mg/dL during the last trimester of 
pregnancy have term infants with birth weights 
below 2500 grams.19 However, it was known from 
this study that there was no relationship between 
serum uric acid level and birth weight or APGAR 
score.
CONCLUSIONS
Maternal blood uric acid levels increased 
signifi cantly accompanying the severity of 
hypertensive disorders in pregnancy. Blood uric 
acid levels tend to be higher in maternal who 
have poor perinatal outcomes.
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